Linked Data API

Show Search Form

Search Results

922333
unstar this property registered interest false more like this
star this property date less than 2018-06-12more like thismore than 2018-06-12
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
unstar this property hansard heading Drugs: Packaging more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of increased uniformity of medication packaging across manufacturers to enable the efficient identification of all medicines. more like this
star this property tabling member constituency York Outer more like this
star this property tabling member printed
Julian Sturdy more like this
star this property uin 152755 remove filter
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-06-20more like thismore than 2018-06-20
star this property answer text <p>The Government has produced guidance in conjunction with experts in clinical practice and in the field of design for those who produce medicines packaging which recommends the judicious use of colour to ensure medicines are well differentiated to reduce the likelihood of error. In developing the principles within this guidance, the views of healthcare professionals and patients have been considered.</p><p> </p><p>While there are detailed legal requirements with respect to the content of the information provided on the packaging there are no provisions with respect to colour and design of the packaging when presented to the market place.</p><p> </p><p>Published research points to the similarity of packaging contributing adversely to selection errors in the pharmacy and other clinical settings. In addition, we are also mindful of the views expressed by patients whereby differences in appearance of medicines from different suppliers can be confusing. Where specific safety issues have been identified, for example with medicines containing warfarin, particular colours both for the tablets and the packaging have been adopted as an industry standard.</p>
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property grouped question UIN
152756 more like this
152757 more like this
star this property question first answered
less than 2018-06-20T16:03:25.817Zmore like thismore than 2018-06-20T16:03:25.817Z
star this property answering member
4065
star this property label Biography information for Jackie Doyle-Price remove filter
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this